ストックスクリーナーアプリを入手
22.10
2.99%
-0.68
アフターアワーズ：
22.36
0.26
+1.18%
前日終値:
$22.78
開ける：
$21.76
24時間の取引高:
233.02K
Relative Volume:
3.10
時価総額：
$228.86M
収益：
$96.10M
当期純損益:
$-31.96M
株価収益率:
-5.4884
EPS:
-4.0267
ネットキャッシュフロー:
$-25.27M
1週間 パフォーマンス:
+3.59%
1か月 パフォーマンス:
+1.14%
6か月 パフォーマンス:
+112.91%
1年 パフォーマンス:
+183.33%
1日の値動き範囲:
$19.77
$25.00
1週間の範囲:
$19.77
$25.00
52週間の値動き範囲:
$5.26
$25.00
Biodesix Inc Stock (BDSX) Company Profile
Compare BDSX vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
22.10 | 230.11M | 96.10M | -31.96M | -25.27M | -4.0267 |
TMO
Thermo Fisher Scientific Inc
|
580.02 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
199.98 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
590.00 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
141.34 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
399.70 | 36.45B | 3.77B | 449.25M | 240.68M | 7.8556 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-05-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-07-26 | 開始されました | Craig Hallum | Buy |
| 2024-05-13 | 開始されました | TD Cowen | Buy |
| 2024-05-03 | 開始されました | Lake Street | Buy |
| 2021-11-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 開始されました | BTIG Research | Buy |
| 2020-11-23 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-23 | 開始されました | Morgan Stanley | Overweight |
| 2020-11-23 | 開始されました | William Blair | Outperform |
すべてを表示
Biodesix Inc (BDSX) 最新ニュース
Biodesix Inc (BDSX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biodesix Inc (BDSX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BDSX|Biodesix Inc|Price:21.900|Chg%:-0.100 - TradingKey
Biodesix Inc (BDSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biodesix Inc (BDSX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Biodesix Inc (BDSX) Income Statement - TradingKey
Biodesix Inc (BDSX) Balance Sheet - TradingKey
Biodesix Inc (BDSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biodesix Inc (BDSX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now? - Yahoo Finance
Biodesix Inc (BDSX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BDSX|Biodesix Inc|Price:22.000|Chg%:-0.320 - TradingKey
Biodesix to report Q2FY26 results on August 5, 2026 - scanx.trade
Biodesix to Report Second Quarter 2026 Financial Results on August 5 - Quiver Quantitative
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026 - Caledonian Record
Biodesix management will give a business update on Aug. 5 - Stock Titan
Biodesix Inc. (BDSX) Holds Steady Near Resistance as Support Levels Remain KeyFactor Momentum - dars.gov.et
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade - MSN
AIGH Capital Management LLC Buys Shares of 758,328 Biodesix, Inc. $BDSX - MarketBeat
Biodesix Inc. (BDSX) Edges Lower Amid Consolidation Near ResistanceMFI Overbought - dars.gov.et
Biodesix (BDSX) chair converts 1,361 RSUs and updates holdings - Stock Titan
Biodesix Inc. (BDSX) Gains Momentum: Key Levels to Watch After 3% RallyPre-Earnings Momentum - dars.gov.et
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Value Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Growth Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Value Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to earnings forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to book forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Biodesix, Inc. Actuals & Estimates (NASDAQ:BDSX) - TradingView
Biodesix (BDSX) Stock Gets Fair Value Bump As Analysts Back Growth Path - Yahoo Finance
Biodesix, Inc. Actuals & Estimates (BOATS:BDSX) - TradingView
BDSX Forecast — Price Target — Prediction for 2027 - TradingView
Biodesix Company Profile & Introduction - Moomoo
BDSX Initiated Coverage by Roth Capital -- Price Target Set at $32 - GuruFocus
Roth Capital Initiates Biodesix at Buy With $32 Price Target - marketscreener.com
Biodesix (BDSX) Coverage Initiated with Positive Outlook - GuruFocus
Biodesix | SCHEDULE 13G/A: Others - Moomoo
Biodesix (BDSX) Surges 10.43%: Key Levels and What Lies AheadLow Volume Node - dars.gov.et
Biodesix (BDSX) surges 10.5%: Is this an indication of further gains? - MSN
Biodesix Inc. (BDSX) Surges Over 10% – Key Levels to WatchBuffered ETF - dars.gov.et
Are medical stocks lagging Biodesix (BDSX) this year? - MSN
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains? - Yahoo Finance
BDSX News | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Soleus discloses 525,241-share (5.1%) stake in Biodesix (BDSX) - Stock Titan
Canaccord raises Biodesix stock price target to $27 on growth outlook By Investing.com - Investing.com Australia
Biodesix Inc (BDSX) 財務データ
収益
当期純利益
現金流量
EPS
Biodesix Inc (BDSX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| O'Kane Kieran | Chief Commercial Officer |
Feb 23 '26 |
Sale |
12.78 |
535 |
6,835 |
9,819 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Feb 23 '26 |
Sale |
12.78 |
535 |
6,835 |
16,231 |
| Vazquez Chris | Chief Accounting Officer |
Feb 23 '26 |
Sale |
12.78 |
211 |
2,696 |
1,586 |
| Hutton Scott | President & CEO |
Feb 23 '26 |
Sale |
12.78 |
1,490 |
19,036 |
48,767 |
1.13%
0.02%
大文字化:
|
ボリューム (24 時間):